Clinical effects of therapy. (A) Comparison of tumor-associated monoclonal Ig (M spike) at baseline versus the value at best response. (B) Differential kinetics of M spike versus serum-free light chains in a patient (P5) with progressive increase in M spike after completion of therapy.